Detection of methylthioadenosine phosphorylase (MTAP) and p16 gene deletion in T cell acute lymphoblastic leukemia by real-time quantitative PCR assay

Leukemia

Volumn 14, Issue 5, 2000, Pages 935-940

  M'soka, T J ^a   Nishioka, J ^a   Taga, A ^a   Kato, K ^a   Kawasaki, H ^a   Yamada, Y ^b   Yu, A ^c   Komada, Y ^a   Nobori, T ^a,d  

^a MIE UNIVERSITY HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ATL; Chromosome 9p deletions; MTAP deficiency; Real time quantitative PCR; T ALL

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; PROTEIN P16;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLAST CELL; BONE MARROW; CHILDHOOD LEUKEMIA; CHROMOSOME 9P; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; FEASIBILITY STUDY; GENE DELETION; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SOUTHERN BLOTTING; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE;

EID: 0034051863     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401771     Document Type: Article

References (34)

1. Batova A, Diccianni MB, Omura-Minamisawa M, Yu J, Carrera CJ, Bridgeman LJ, Kung FH, Pullen J, Amylon MD, Yu AL. Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro. Cancer Res 1999; 59: 1492-1497.
2. Kamatani N, Nelson-Rees WA, Carson DA. Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme. Proc Natl Acad Sci USA 1981; 78: 1219-1223.
3. Batova A, Diccianni MB, Nobori T, Vu T, Yu J, Bridgeman L, Yu AL. Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy. Blood 1996; 88: 3083-3090.
4. Pegg AE, Williams-Ashman HG. Phosphate-stimulated breakdown of 5′-methylthioadenosine by rat ventral prostate. Biochem J 1969; 115: 241-247.
5. Backlund PS Jr, Smith RA. Methionine synthesis from 5′-methylthioadenosine in rat liver. J Biol Chem 1981; 256: 1533-1535.
6. Kamatani N, Carson DA. Dependence of adenine production upon polyamine synthesis in cultured human lymphoblasts. Biochim Biophys Acta 1981; 675: 344-350.
7. Toohey JI. Methylthioadenosine nucleoside phosphorylase deficiency in methylthio-dependent cancer cells. Biochem Biophys Res Commun 1978; 83: 27-35.
8. Kamatani N, Carson DA. Abnormal regulation of methylthioadenosine and polyamine metabolism in methylthioadenosine phosphorylase-deficient human leukemic cell lines. Cancer Res 1980; 40: 4178-4182.
9. Fitchen JH, Riscoe MK, Dana BW, Lawrence JH, Ferro AJ. Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors. Cancer Res 1986; 46: 5409-5412.
10. Nobori T, Karras JG, Della Ragione F, Waltz TA, Chen PP, Carson DA. Absence of methylthioadenosine phosphorylase in human gliomas. Cancer Res 1991; 51: 3193-3197.
11. Nobori T, Szinai I, Amox D, Parker B, Olopade OI, Buchhagen DL, Carson DA. Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers. Cancer Res 1993; 53: 1098-1101.
12. Sahota A, Webster DR, Potter CF, Simmonds HA, Rodgers AV, Gibson T. Methylthioadenosine phosphorylase activity in human erythrocytes. Clin Chim Acta 1983; 128: 283-290.
13. Yu J, Batova A, Shao L, Carrera CJ, Yu AL. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP(-) malignancies. Clin Cancer Res 1997; 3: 433-438.
14. Hori H, Tran P, Carrera CJ, Hori Y, Rosenbach MD, Carson DA, Nobori T. Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells. Cancer Res 1996; 56: 5653-5658.
15. Chen ZH, Zhang H, Savarese TM. Gene deletion chemoselectivity: codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, and the α-and β-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy. Cancer Res 1996; 56: 1083-1090.
16. Chen ZH, Olopade OI, Savarese TM. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP-malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis. Mol Pharmacol 1997; 52: 903-911.
17. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stocken E, Day RS III, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
18. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753-756.
19. Nobori T, Takabayashi K, Tran P, Orvis L, Batova A, Yu AL, Carson DA. Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers. Proc Natl Acad Sci USA 1996; 93: 6203-6208.
20. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 1994; 84: 2431-2435.
21. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 1995; 55: 20-23.
22. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res 1995; 55: 1448-1451.
23. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995; 85: 2321-2330.
24. INK4b gene in acute type adult T-cell leukemia. Int J Cancer 1998; 75: 51-56.
25. Shimoyama M and members of The Lymphoma Study Group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991; 79: 428-437.
26. Yamada Y, Hatta Y, Murata K, Sugawara K, Ikeda S, Mine M, Maeda T, Hirakata Y, Kamihira S, Tsukasaki K, Ogawa S, Hirai H, Koeffler HP, Tomonaga M. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J Clin Oncol 1997; 15: 1778-1785.
27. Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood 1995; 85: 2699-2704.
28. Diccianni MB, Batova A, Yu J, Vu T, Pullen J, Amylon M, Pollock BH, Yu AL. Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions. Leukemia Res 1997; 21: 549-558.
29. Perry A, Nobori T, Ru N, Anderl K, Borell TJ, Mohapatra G, Feuerstein BG, Jenkins RB, Carson DA. Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR. J Neuropath Exp Neur 1997; 56: 999-1008.
30. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 986-994.
31. Lockey C, Otto E, Long Z. Real-time fluorescence detection of a single DNA molecule. Biotechniques 1998; 24: 744-746.
32. Tran PT, Hori H, Hori Y, Okumura K, Kagotani K, Taguchi H, Carson DA, Nobori T. Molecular cloning of the human methylthioadenosine phosphorylase processed pseudogene and localization to 3q28. Gene 1997; 186: 263-269.
33. Cairns P, Sidransky D. Molecular methods for the diagnosis of cancer. Biochim Biophys Acta 1999; 1423: C11-C18.
34. Takeuchi S, Koike M, Seriu T, Bartram CR, Slater J, Park S, Miyoshi I, Koeffler HP. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis. Leukemia 1997; 11: 1636-1640.